The 2018 Cell Therapy conference, hosted by IABS and CIRM, will identify key unresolved issues that need to be addressed for the manufacture and testing of pluripotent stem cell-based therapies and provide scientific consensus on selected aspects to inform the drafting of future national and international guidance.
SCB will present the latest project status and future directions at an evening session, "Breaking News in Standards for Regenerative Medicine".